Join the Psymposia crew at 4PM ET this Saturday, October 17, at the Capital Psychedelic Summit, organized by District Psychedelic and the D.C. Psychedelic Society. Register for free here.

Washington, D.C. is preparing to vote on decriminalization, and polling indicates the initiative has the numbers to pass. What does decriminalization mean in The District of Columbia, both for residents and the nation as a whole?

How does the “Grow, Gather, Give” model promote access to underserved communities? What are the implications for Drug Policy? What risks will businesses take to explore the market? ​The Capital Psychedelic Summit offers a frank discussion on the real world ramifications of changing policies and attitudes toward psychedelics.

View the full weekend schedule here.


And we fully concur with this piece they have just published – let’s not go down the same suit ridden road as cannabis sadly has

Psychedelic Media Should Stop Parroting Corporate Press Releases

When the media republishes statements from psychedelic pharmaceutical startups and their executives with little-to-no vetting, it functions as a corporate megaphone and damages the field of psychedelic science.